NeuroTherapeutics Pharma, Inc.: Series B $43M

Posted in I - Series B, Q - 2Q10, R - MID WEST, X - CNS, X - Epilepsy, X - Pain, XX - IL

NeuroTherapeutics Pharma (Chicago, IL) a clinical-stage biopharmaceutical company focused on the CNS disorders of epilepsy, acute and neuropathic pain, closed a $43M Series B financing. Participants include Fidelity Biosciences, MPM Capital, S.R. One, Pfizer, Novo Ventures and Thomas McNerney & Partners.

Mar

2009

Ikano Therapeutics, Inc.: Series B $9M

Posted in I - Series B, Q - 1Q09, R - SOUTH EAST, X - Epilepsy, X - Pain, X - Seizures, XX - KY

Ikano Therapeutics (Lexington, KY) a clinical-stage nasal delivery platform company focused on seizures and pain, closed a $9M Series B financing, the final tranche of a $18M round. Participants include SV Life Sciences, Burrill & Co., Tullis-Dickerson, Fidelity Biosciences, Apjohn Ventures, Fort Washington Capital, Commonwealth Seed Capital and Kentucky Co-Investment Partners.

Dec

2008

CeNeRx BioPharma, Inc.: Series B $15M

Posted in I - Series B, Q - 4Q08, R - SOUTH EAST, X - Anxiety, X - Depression, X - Epilepsy

CeNeRx BioPharma (Cary, NC) developer of CNS therapeutics for depression, anxiety and
epilepsy, closed a $15M Series B financing. Participants include Aisling Capital, L Capital Partners and Pappas Ventures.

Dec

2008

Sierra Neuropharmaceuticals: Series A $21.5M

Posted in I - Series A, Q - 3Q08, R - ROCKY MOUNTAIN, X - Epilepsy, X - Neurology, X - Schizophrenia

Sierra Neuropharmaceuticals (Aurora, CO) development-stage biopharmaceutical company specializing treating neurological disorders, closed a $21.5M Series A financing. Participants include HealthCare Ventures, Morgenthaler Ventures, Sequel Ventures and High Country Venture.

to top of page...